Open AccessApproaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin
Author(s) -
Yu. М. Gomon,
А. Р. Касимова,
А. С. Колбин,
V. V. Strizheletsky,
И. Г. Иванов,
С. О. Мазуренко
Publication year - 2022
Publication title -
bezopasnostʹ i risk farmakoterapii
Language(s) - English
Resource type - Journals
eISSN - 2619-1164
pISSN - 2312-7821
DOI - 10.30895/2312-7821-2022-10-3-283-292
Subject(s) - azithromycin , medicine , covid-19 , medical prescription , pandemic , medline , adverse effect , drug reaction , alternative medicine , intensive care medicine , family medicine , pharmacology , drug , pathology , disease , political science , law , infectious disease (medical specialty) , microbiology and biotechnology , biology , antibiotics